Ferroptosis: is it both cause and effect in refractory epilepsy?

Jerónimo Auzmendi , Alberto Lazarowski

Exploration of Neuroscience ›› 2025, Vol. 4 ›› Issue (1) : 100692

PDF (1419KB)
Exploration of Neuroscience ›› 2025, Vol. 4 ›› Issue (1) :100692 DOI: 10.37349/en.2025.100692
research-article
Ferroptosis: is it both cause and effect in refractory epilepsy?
Author information +
History +
PDF (1419KB)

Abstract

All living beings, from microorganisms to plants, animals, and humans, require iron as an essential micronutrient for their lives. However, iron overload can constitute a scenario prone to damage to the organism, including oxidative stress, deterioration of cellular and subcellular membranes, and thus leading to cell death. This process involves unrestricted lipid peroxidation caused by the generation of reactive oxygen species (ROS) because of an abrupt increase in free Fe2+ in the cytoplasm, all of which leads to subsequent membrane damage and iron-dependent cell death, now known as “ferroptosis”. This process can be induced by convulsive stress, and conversely, inducing seizures, and in both situations under a context of neuroinflammation. In this critical review, we will highlight the most relevant aspects of this recently described mechanism, which has been studied little in epilepsy, its impact on the prognosis of the disease, and its effects on the development of central and/or peripheral comorbidities, including SUDEP (sudden unexpected death in epilepsy).

Keywords

Brain iron accumulation / ferroptosis / epileptogenesis / sudden unexpected death in epilepsy / hemosiderin

Cite this article

Download citation ▾
Jerónimo Auzmendi, Alberto Lazarowski. Ferroptosis: is it both cause and effect in refractory epilepsy?. Exploration of Neuroscience, 2025, 4 (1) : 100692 DOI:10.37349/en.2025.100692

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Trousseau A.Lectures on clinical medicine2nd edPhiladelphia:Lindsay & Blakiston1873

[2]

Alvira DR,Navarro LG,Lázaro MAG,Collado ER.Oxidative stress and infectious pathology.An Med Interna.1995;12:139-49. Spanish.

[3]

Oppenheimer SJ.Iron and its relation to immunity and infectious disease.J Nutr.2001;131:616S-35S.

[4]

Silva-Gomes S,Vale-Costa S,Appelberg R,Gomes MS.Iron in intracellular infection: to provide or to deprive?Front Cell Infect Microbiol.2013;3:96.

[5]

Sheftel AD,Mason AB,Ponka P.The long history of iron in the Universe and in health and disease.Biochim Biophys Acta.2012;1820:161-87.

[6]

Dixon SJ,Lemberg KM,Lamprecht MR,Skouta R,Zaitsev EM,Gleason CE,et al.Ferroptosis: an iron-dependent form of nonapoptotic cell death.Cell.2012;149:1060-72.

[7]

Tombini M,Squitti R,Cacciapaglia F,Ventriglia M,Assenza G,Benvenga A,et al.Inflammation and iron metabolism in adult patients with epilepsy: does a link exist?Epilepsy Res.2013;107:244-52.

[8]

Khan S,Bano N,Ahamad S,John U,Dar NJ,Bhat SA.Excitotoxicity, Oxytosis/Ferroptosis, and Neurodegeneration: Emerging Insights into Mitochondrial Mechanisms.Aging Dis.2024

[9]

Quiles Del Rey M,Mancias JD.NCOA4-Mediated Ferritinophagy: A Potential Link to Neurodegeneration.Front Neurosci.2019;13:238.

[10]

Liu L,Gao W,Yang S,Yang F,Li S,Tian Y,et al.Ferritinophagy-Mediated Hippocampus Ferroptosis is Involved in Cognitive Impairment in Immature Rats Induced by Hypoxia Combined with Propofol.Neurochem Res.2024;49:1703-19.

[11]

Feng L,Yin X,Hua Q,Ren T,Ke J.Advancements in understanding the role of ferroptosis in hypoxia-associated brain injury: a narrative review.Transl Pediatr.2024;13:963-75.

[12]

Auzmendi J,Lazarowski A.Seizures Induce Hypoxia, and Hypoxia Induces Seizures: A Perverse Relationship That Increases the Risk of Sudden Unexpected Death in Epilepsy (SUDEP). In: Rocha LL,Lazarowski A,Cavalheiro EA. editors.Pharmacoresistance in Epilepsy: From Genes and Molecules to Promising Therapies.Cham:Springer2023.pp. 207–37.

[13]

Merelli A,Repetto M,Lazarowski A,Auzmendi J.Hypoxia, Oxidative Stress, and Inflammation: Three Faces of Neurodegenerative Diseases.J Alzheimers Dis.2021;82:S109-26.

[14]

Feng S,Tang D,Wang Y,Li X,Bao H,Tang C,et al.The mechanism of ferroptosis and its related diseases.Mol Biomed.2023;4:33.

[15]

Mesraoua B,Brigo F,Lattanzi S,Abou-Khalil B,Hail HA,Asadi-Pooya AA.Drug-resistant epilepsy: Definition, pathophysiology, and management.J Neurol Sci.2023;452:120766.

[16]

Czornyj L,Auzmendi J,Lazarowski A.Transporter hypothesis in pharmacoresistant epilepsies. Is it at the central or peripheral level?Epilepsia Open.2022;7 Suppl 1:S34-46.

[17]

Tang F,Hartz AMS,Bauer B.Drug-Resistant Epilepsy: Multiple Hypotheses, Few Answers.Front Neurol.2017;8:301.

[18]

Höcht C,Lazarowski A,Gonzalez NN,Auzmendi J,Opezzo JAW,Bramuglia GF,et al.Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic model.Neurosci Lett.2007;413:168-72.

[19]

Höcht C,Lazarowski A,Gonzalez NN,Mayer MA,Opezzo JAW,Taira CA,et al.Differential hippocampal pharmacokinetics of phenobarbital and carbamazepine in repetitive seizures induced by 3-mercaptopropionic acid.Neurosci Lett.2009;453:54-7.

[20]

Díaz-Coranguez M,Auzmendi J,Fuentes-Mejia M,Cosme TGM,Lazarowski A,Rocha L.Barriers of the CNS and Their Contribution to Drug-Resistant Epilepsy. In: Talevi A. editors.CNS Drug Development and Delivery: Concepts and Applications.Cham:Springer2024.pp. 181–211.

[21]

Auzmendi J,Buchholz B,Salguero J,Cañellas C,Kelly J,Men P,et al.Pilocarpine-Induced Status Epilepticus Is Associated with P-Glycoprotein Induction in Cardiomyocytes, Electrocardiographic Changes, and Sudden Death.Pharmaceuticals (Basel).2018;11:21.

[22]

Auzmendi J,Merelli A,Girardi E,Orozco Suárez S,Rocha L,Lazarowski A.Progressive heart P-glycoprotein (P-gp) overexpression after experimental repetitive seizures (ERS) associated with fatal status epilepticus (FSE). Is it related with SUDEP?Mol Cell Epilepsy.2014;1:43-51.

[23]

Auzmendi J,Salgueiro J,Canellas C,Zubillaga M,Men P,Alicia R,et al.Pilocarpine-induced Status Epilepticus (SE) induces functional and histological P-glycoprotein overexpression in cardiomyocytes, heart dysfunction and high ratio of sudden death in rats. Proceeding of the Annual Meeting of American Epilepsy Society; 2017 Nov 20; DC, USA. Washington: American Epilepsy Society; 2017. pp. 1–5.

[24]

Akyuz E,Doganyigit Z,Eroglu E,Moscovicz F,Merelli A,Lazarowski A,et al.Myocardial Iron Overload in an Experimental Model of Sudden Unexpected Death in Epilepsy.Front Neurol.2021;12:609236.

[25]

Lazarowski A,Sevlever G,Taratuto A,Massaro M,Rabinowicz A.Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy.Pediatr Neurol.1999;21:731-4.

[26]

Lazarowski A,Ramos AJ,García-Rivello H,Brusco A,Girardi E.Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.Cell Mol Neurobiol.2004;24:77-85.

[27]

Lazarowski A,Czornyj L,Lubienieki F,Girardi E,Vazquez S,D’Giano C.ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.Epilepsia.2007;48 Suppl 5:140-9Erratum in: Epilepsia. 2007;48:2380.

[28]

Ramos AJ,Lazarowski A,Villar MJ,Brusco A.Transient expression of MDR-1/P-glycoprotein in a model of partial cortical devascularization.Cell Mol Neurobiol.2004;24:101-7.

[29]

Lazarowski A,Caltana L,Merelli A,Rubio MD,Ramos AJ,Brusco A.Neuronal mdr-1 gene expression after experimental focal hypoxia: a new obstacle for neuroprotection?J Neurol Sci.2007;258:84-92.

[30]

Merelli A,Ramos AJ,Lazarowski A,Auzmendi J.Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity.Front Neurosci.2019;13:750.

[31]

Petrillo S,Pietrafusa N,Trivisano M,Calabrese C,Saura F,Gallo MG,et al.Imbalance of Systemic Redox Biomarkers in Children with Epilepsy: Role of Ferroptosis.Antioxidants (Basel).2021;10:1267.

[32]

Mao X,Zhou H,Jin W.Ferroptosis Induction in Pentylenetetrazole Kindling and Pilocarpine-Induced Epileptic Seizures in Mice.Front Neurosci.2019;13:721.

[33]

Zimmer TS,David B,Broekaart DWM,Schidlowski M,Ruffolo G,Korotkov A,et al.Seizure-mediated iron accumulation and dysregulated iron metabolism after status epilepticus and in temporal lobe epilepsy.Acta Neuropathol.2021;142:729-59.

[34]

Ye Q,Zeng C,Luo C,Wu Y.Ferrostatin-1 mitigates cognitive impairment of epileptic rats by inhibiting P38 MAPK activation.Epilepsy Behav.2020;103:106670.

[35]

Chen K,Guan Q,Yin X,Wang Z,Zhou H,Mao X.Ferrostatin-1 obviates seizures and associated cognitive deficits in ferric chloride-induced posttraumatic epilepsy via suppressing ferroptosis.Free Radic Biol Med.2022;179:109-18.

[36]

Zhang X,Wu S,Guo C,Guo K,Hu Z,Peng J,et al.Vitamin E Exerts Neuroprotective Effects in Pentylenetetrazole Kindling Epilepsy via Suppression of Ferroptosis.Neurochem Res.2022;47:739-47.

[37]

Xiang T,Luo X,Zeng C,Li S,Ma M,Wu Y.Klotho ameliorated cognitive deficits in a temporal lobe epilepsy rat model by inhibiting ferroptosis.Brain Res.2021;1772:147668.

[38]

Reid BM.Early life stress and iron metabolism in developmental psychoneuroimmunology.Brain Behav Immun Health.2024;40:100824.

[39]

Urrutia P,Aguirre P,Esparza A,Tapia V,Mena NP,Arredondo M,et al.Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells.J Neurochem.2013;126:541-9.

[40]

Santana-Codina N,Gikandi A,Mancias JD.The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis.Adv Exp Med Biol.2021;1301:41-57.

[41]

Xie Y,Zhou Y,Wang J,Du L,Ren Y,Liu F.Ferroptosis, autophagy, tumor and immunity.Heliyon.2023;9:e19799.

[42]

Xie L,He Q,Wu H,Shi W,Xiao X,Yu T.Hydrogen Sulfide Sustained Release Donor Alleviates Spinal Cord Ischemia-Reperfusion-Induced Neuron Death by Inhibiting Ferritinophagy-Mediated Ferroptosis.CNS Neurosci Ther.2025;31:e70366.

[43]

Chen X,Liu L,Jiang W,Hu Y,Zou W,Zhang P,et al.Hydrogen Sulfide Inhibits Ferritinophagy-Mediated Ferroptosis in the Hippocampus of Rotenone-Exposed Rats.J Physiol Investig.2025;68:91-9.

[44]

Gorter JA,Mesquita ARM,van Vliet EA,da Silva FH,Aronica E.Increased expression of ferritin, an iron-storage protein, in specific regions of the parahippocampal cortex of epileptic rats.Epilepsia.2005;46:1371-9.

[45]

Moos WH,Faller DV,Glavas IP,Kanara I,Kodukula K,Pernokas J,et al.Epilepsy: Mitochondrial connections to the ‘Sacred’ disease.Mitochondrion.2023;72:84-101.

[46]

Li X,Quan P,Si Y,Liu F,Fan Y,Ding F,et al.The microRNA-211-5p/P2RX7/ERK/GPX4 axis regulates epilepsy-associated neuronal ferroptosis and oxidative stress.J Neuroinflammation.2024;21:13.

[47]

Wang D,Cui Y,Gao F,Zheng W,Li J,Xian Z.Keap1/Nrf2 signaling pathway participating in the progression of epilepsy via regulation of oxidative stress and ferroptosis in neurons.Clinics (Sao Paulo).2024;79:100372.

[48]

Folbergrová J,Ješina P,Otáhal J.Protective Effect of Sulforaphane on Oxidative Stress and Mitochondrial Dysfunction Associated with Status Epilepticus in Immature Rats.Mol Neurobiol.2023;60:2024-35.

[49]

Gao J,An L,Xu Y,Huang Y.Catalpol Exerts an Anti-Epilepticus Effect, Possibly by Regulating the Nrf2-Keap1-ARE Signaling Pathway.Med Sci Monit.2018;24:9436-41.

[50]

Hu Q,Yan H,Peng F,Feng W,Chen F,Huang X,et al.Genistein protects epilepsy-induced brain injury through regulating the JAK2/STAT3 and Keap1/Nrf2 signaling pathways in the developing rats.Eur J Pharmacol.2021;912:174620.

[51]

Li D,Bai X,Jiang Y,Cheng Y.Butyrate alleviates PTZ-induced mitochondrial dysfunction, oxidative stress and neuron apoptosis in mice via Keap1/Nrf2/HO-1 pathway.Brain Res Bull.2021;168:25-35.

[52]

Kishore M,Pradeep M,Narne P,Jayalakshmi S,Panigrahi M,Patil A,et al.Regulation of Keap1-Nrf2 axis in temporal lobe epilepsy-hippocampal sclerosis patients may limit the seizure outcomes.Neurol Sci.2023;44:4441-50Erratum in: Neurol Sci. 2024;45:377.

[53]

Liu Z,Yin X,Liu L,Tao H,Zhou H,Ma G,et al.Association of KEAP1 and NFE2L2 polymorphisms with temporal lobe epilepsy and drug resistant epilepsy.Gene.2015;571:231-6.

[54]

Alcoreza OB,Patel DC,Tewari BP,Sontheimer H.Dysregulation of Ambient Glutamate and Glutamate Receptors in Epilepsy: An Astrocytic Perspective.Front Neurol.2021;12:652159.

[55]

Ottestad-Hansen S,Hu QX,Follin-Arbelet VV,Bentea E,Sato H,Massie A,et al.The cystine-glutamate exchanger (xCT, Slc7a11) is expressed in significant concentrations in a subpopulation of astrocytes in the mouse brain.Glia.2018;66:951-70.

[56]

Aloi MS,Thompson SJ,Quartapella N,Noebels JL.Loss of functional System x-c uncouples aberrant postnatal neurogenesis from epileptogenesis in the hippocampus of Kcna1-KO mice.Cell Rep.2022;41:111696.

[57]

Nielsen S,Nagelhus EA,Amiry-Moghaddam M,Bourque C,Agre P,Ottersen OP.Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain.J Neurosci.1997;17:171-80.

[58]

During MJ,Spencer DD.Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain.Lancet.1993;341:1607-10.

[59]

Robert SM,Buckingham SC,Campbell SL,Robel S,Holt KT,Ogunrinu-Babarinde T,et al.SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.Sci Transl Med.2015;7:289ra86.

[60]

Campbell SL,Buckingham SC,Sontheimer H.Human glioma cells induce hyperexcitability in cortical networks.Epilepsia.2012;53:1360-70.

[61]

Buckingham SC,Campbell SL,Haas BR,Montana V,Robel S,Ogunrinu T,et al.Glutamate release by primary brain tumors induces epileptic activity.Nat Med.2011;17:1269-74.

[62]

Alcoreza O,Jagarlamudi S,Savoia A,Campbell SL,Sontheimer H.Sulfasalazine decreases astrogliosis-mediated seizure burden.Epilepsia.2022;63:844-54.

[63]

De Bundel D,Schallier A,Loyens E,Fernando R,Miyashita H,Van Liefferinge J,et al.Loss of system x(c)- does not induce oxidative stress but decreases extracellular glutamate in hippocampus and influences spatial working memory and limbic seizure susceptibility.J Neurosci.2011;31:5792-803.

[64]

Leclercq K,Van Liefferinge J,Albertini G,Neveux M,Dardenne S,Mairet-Coello G,et al.Anticonvulsant and antiepileptogenic effects of system xc- inactivation in chronic epilepsy models.Epilepsia.2019;60:1412-23.

[65]

Vecchia SD,Marchese M,Santorelli FM.Glial Contributions to Lafora Disease: A Systematic Review.Biomedicines.2022;10:3103.

[66]

Swoboda KJ,Margraf RL,Carey JC,Zhou H,Newcomb TM,Coonrod E,et al.A novel germline PIGA mutation in Ferro-Cerebro-Cutaneous syndrome: a neurodegenerative X-linked epileptic encephalopathy with systemic iron-overload.Am J Med Genet A.2014;164A:17-28.

[67]

Muckenthaler L,Marques O,Colucci S,Kunz J,Fabrowski P,Bast T,et al.Constitutional PIGA mutations cause a novel subtype of hemochromatosis in patients with neurologic dysfunction.Blood.2022;139:1418-22.

[68]

Heidari M,Gerami SH,Bassett B,Graham RM,Chua ACG,Aryal R,et al.Pathological relationships involving iron and myelin may constitute a shared mechanism linking various rare and common brain diseases.Rare Dis.2016;4:e1198458.

[69]

Ikeda M.Iron overload without the C282Y mutation in patients with epilepsy.J Neurol Neurosurg Psychiatry.2001;70:551-3.

[70]

Guo M,Zhang L,Chen K,Huang D,Feng C,Liu H,et al.Hemophagocytic lymphohistiocytosis associated with brucellosis.Diagn Microbiol Infect Dis.2024;109:116289.

[71]

Perruccio K,Arcioni F,Cerri C,Starza RL,Romanelli D,Capolsini I,et al.The hereditary hyperferritinemia-cataract syndrome in 2 italian families.Case Rep Pediatr.2013;2013:806034.

[72]

Devos D,Tchofo PJ,Vuillaume I,Destée A,Batey S,Burn J,et al.Clinical features and natural history of neuroferritinopathy caused by the 458dupA FTL mutation.Brain.2009;132:e109.

[73]

Shieh JT,Tintos-Hernandez JA,Murali CN,Penon-Portmann M,Flores-Mendez M,Santana A,et al.Heterozygous nonsense variants in the ferritin heavy-chain gene FTH1 cause a neuroferritinopathy.HGG Adv.2023;4:100236.

[74]

Silva B,Faustino P.An overview of molecular basis of iron metabolism regulation and the associated pathologies.Biochim Biophys Acta.2015;1852:1347-59.

[75]

Tang D,Chen X,Kang R,Kroemer G.Ferroptosis: molecular mechanisms and health implications.Cell Res.2021;31:107-25.

[76]

Zanello M,Goodden JR,Colle H,Wager M,De Witt Hamer PC,Smits A,et al.Predictors of Epileptic Seizures and Ability to Work in Supratentorial Cavernous Angioma Located Within Eloquent Brain Areas.Neurosurgery.2019;85:E702-13.

[77]

Roelcke U,Boxheimer L,Fathi AR,Schwyzer L,Ortega M,Berberat J,et al.Cortical hemosiderin is associated with seizures in patients with newly diagnosed malignant brain tumors.J Neurooncol.2013;115:463-8.

[78]

Liu Q,Wang Y,Tan D,Liu Y,Zhang P,Ma L,et al.The Prevention and Reversal of a Phenytoin-Resistant Model by N-acetylcysteine Therapy Involves the Nrf2/P-Glycoprotein Pathway at the Blood-Brain Barrier.J Mol Neurosci.2022;72:2125-35.

[79]

Zolotoff C,Voirin A,Puech C,Roche F,Perek N.Intermittent Hypoxia and Its Impact on Nrf2/HIF-1α Expression and ABC Transporters: An in Vitro Human Blood-Brain Barrier Model Study.Cell Physiol Biochem.2020;54:1231-48.

[80]

Liang Z,Guo Q,Zheng Z,Lou Y,Zhu X,Liu S.Hypoxia-inducible factor 1α inhibitor reduces hippocampal neuronal ferroptosis.Neural Regen Res.2025

PDF (1419KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/